Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
April 2026 update: On April 15, 2026, the FDA published an update removing BPC-157 from the Category 2 list
The committee's review was limited to specific nominated indications, but compounding pharmacies, if permitted to produce these substances, could legally dispense them for any condition a physician prescribes
Store at room temperature, away from direct sunlight
This selectivity is theoretically advantageous because it avoids the hyperglycemia, carpal tunnel syndrome, and insulin resistance associated with systemic GH therapy
Comorbidity: Substance use disorders and other mental illnesses
Its scientific value lies in helping researchers explore cytoprotection, cell migration, and tissue-repair-associated mechanisms under controlled experimental conditions
US$ 27.72
US$ 25.85
US$ 29.37
US$ 22.67
